www.lilly.com
Open in
urlscan Pro
54.237.133.81
Public Scan
Submitted URL: http://lilly.com/
Effective URL: https://www.lilly.com/
Submission: On May 30 via manual from IN — Scanned from DE
Effective URL: https://www.lilly.com/
Submission: On May 30 via manual from IN — Scanned from DE
Form analysis 0 forms found in the DOM
Text Content
Accessibility Statement
Skip to main content
This website uses cookies and other technologies to personalize content and ads
on this and other websites and provide social media services. By clicking “I
Agree” you consent to our use of tracking technologies and disclosure of
tracking data to third party ad networks or social media companies for the
purposes above. If you click “I Disagree” you can still use this website. For
more information about Lilly’s privacy practices, click here .
I Disagree I Agree
* ESG Report
* Careers
* Partners
* Investors
* Contact
* Globe
Lilly
Menu Menu
Menu closed
Lilly
Close Close
* Company
Expand mega menu
Expand submenu
Collapse Company Company
WHO WE ARE
Expand
* About Lilly
* Key Facts
* Recognitions
* Powered by Purpose
LEADERSHIP
Expand
* Governance
* Executive Committee
* Board of Directors
POLICIES & REPORTS
Expand
* Public Policy
* Annual Report & Proxy Statement
* Year in Review
* Science
Expand mega menu
Expand submenu
Collapse Science Science
DISCOVERY
Expand
* Clinical Development Pipeline
* Research & Scientific Discovery
* Principles of Medical Research
* The Elixir Factor Podcast
* 100 Years of Insulin
DISEASE AREAS
Expand
* Alzheimer's
* Cancer
* Diabetes
* Immunology
* Obesity
* Pain
CLINICAL RESEARCH
Expand
* Clinical Trials
* Diversity in Clinical Trials
* Lilly Trials
* Expanded Access
* CSR Synopses
PARTNERS
Expand
* Collaborate With Us
* Scientific Areas of Interest
* Our Approach to Partnering
* Office of Alliance Management
* Lilly Research Award Program
* Medicines
Expand mega menu
Expand submenu
Collapse Medicines Medicines
SAFETY
Expand
* Patient Safety
* Medication Safety
* Manufacturing & Quality
OUR MEDICINES
Expand
* Current Medicines
* Historic Medicines
* Suggestions for Patients
RESOURCES
Expand
* Lilly Insulin Access Programs
* Lilly Insulin State Patient Assistance Programs
* Lilly Oncology Support Center
* Lilly Pricing Information
* The Lilly Answers Center
* Lilly Cares Foundation
* Insulin Affordability
* Impact
Expand mega menu
Expand submenu
Collapse Impact Impact
OUR IMPACT
Expand
* Overview
* Lilly Foundation
* Lilly Grant Office
IMPACT AREAS
Expand
* Increase Access to Medicines
* Improve Lives and Communities
* Empower a Diverse Workforce
* Minimize Our Environmental Impact
* Operate Ethically and Responsibly
TRANSPARENCY
Expand
* ESG Report
* State-Specific Requirements
* News
Expand mega menu
Expand submenu
Collapse News News
STORIES
Expand
* Caring
* Science
* Policy
* All Stories
PRESS RELEASES
Expand
* Recent
* Archives
MEDIA
Expand
* All News
* Media Kits
* Media Contacts
* Social Media Guidelines
*
* Search
* ESG Report
* Careers
* Partners
* Investors
* Contact
* Globe
Close alert Information
Learn about Lilly’s Insulin Affordability Solutions
EASIER ACCESS TO LILLY INSULIN
People who rely on insulin to manage diabetes deserve affordable access. We’ve
announced changes that make it easier for people to get Lilly insulin for $35 or
less a month.
See the Details
LATEST NEWS
Read All
View All Down
--------------------------------------------------------------------------------
Lilly to Participate in Goldman Sachs Global Healthcare Conference
May 30, 2023
Tags | Financial
INDIANAPOLIS , May 30, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY)
will attend the Goldman Sachs 44th Annual Global Healthcare Conference, June
12-13, 2023 . Anat Ashkenazi , Lilly executive vice president and chief
financial officer, will participate in a fireside chat on June 12 at
--------------------------------------------------------------------------------
Lilly ESG Report Highlights Progress Towards Sustainability Goals
May 22, 2023
Tags | Impact
Reduced greenhouse gas emissions by 20% Improved access to Lilly insulins in the
U.S. Nearly doubled patients reached in resource-limited settings through global
health efforts INDIANAPOLIS , May 22, 2023 /PRNewswire/ -- Eli Lilly and Company
(NYSE: LLY) today released its latest Environmental,
--------------------------------------------------------------------------------
Lilly's peresolimab Phase 2a rheumatoid arthritis trial published in The New
England Journal of Medicine
May 18, 2023
Tags | Product
Peresolimab met the primary efficacy endpoint in patients with refractory
rheumatoid arthritis (RA) Study evaluated a novel approach to treating patients
with autoimmune diseases INDIANAPOLIS , May 18, 2023 /PRNewswire/ -- The New
England Journal of Medicine today published detailed results from
--------------------------------------------------------------------------------
Loxo@Lilly Announces Details of Presentations at 2023 European Hematology
Association (EHA) Annual Meeting
May 11, 2023
Tags | Product
INDIANAPOLIS , May 11, 2023 /PRNewswire/ -- Loxo@Lilly, the oncology unit of Eli
Lilly and Company (NYSE: LLY), today announced that data from its oncology
portfolio will be presented at the 2023 European Hematology Association (EHA)
Annual Meeting, to be held June 8 – 11, 2023, in Frankfurt,
--------------------------------------------------------------------------------
Lilly's Social Impact Venture Capital Portfolio Poised to Grow to $300 Million
with New $50 Million Allocation
May 9, 2023
Tags | Impact
INDIANAPOLIS , May 9, 2023 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) has
allocated an additional $50 million to its now $300 million Social Impact
Venture Capital Portfolio, reflecting the company's commitment to going beyond
the medicines it makes to have a positive impact on patients and
--------------------------------------------------------------------------------
View All Press Releases
THE LATEST
--------------------------------------------------------------------------------
EASIER ACCESS TO AFFORDABLE LILLY INSULIN
ESG
2022 ESG REPORT
See the progress we're making towards our environmental, social and governance
goals.
News
OUR LATEST MEDICINES AND PRODUCTS
Learn more about what's new for patients.
Social Impact
IMPROVING ACCESS TO MEDICINES
Our commitment to social impact inspires how we work to expand access to our
medicines and tackle complex global health challenges.
DRIVING INNOVATION
--------------------------------------------------------------------------------
Up Expand
INNOVATION COMES TO LIFE IN MANUFACTURING
The push towards breakthrough discoveries isn’t confined to our labs. Innovation
is imbedded in all we do and helps us continue to find better, smarter, faster
ways to reach more people.
INCREASING ACCESS
--------------------------------------------------------------------------------
Up Expand
PARTNERING FOR BETTER ACCESS
Breast cancer kills more Black women in the U.S. than any other racial group.
When we join forces across the healthcare space, we can have a greater impact to
help close healthcare gaps.
OUR MEDICINES
--------------------------------------------------------------------------------
Continuously Working to Find More Options
We’re always in search of the next breakthrough that will help reach more people
with our treatments.
View Our Medicines
INNOVATION IN ALZHEIMER'S
--------------------------------------------------------------------------------
We Learn More with Every Research Milestone
We've been working to find the key to unlocking Alzheimer's disease for more
than 30 years.
See the Timeline
COMMUNITY IMPACT
--------------------------------------------------------------------------------
Making an Impact Beyond Medicine
Beyond our medicines, we positively impact society through our work to improve
lives and communities around the world.
Read About Our Impact
* Diversity
* Contact
* Suppliers
* Login
*
* Terms of Use
* Privacy Statement
* Accessibility Statement
* Sitemap
To speak to customer support:
Call (800) 545-5979
This site is intended for U.S. residents ages 18 and older.
Copyright © 2023 Lilly. All rights reserved.
Cookie Settings
Twitter Facebook Instagram LinkedIn YouTube
Terms of Use Privacy Statement Accessibility Statement Sitemap
Lilly